Ha Tinh Pharmaceutical JSC (UPCoM: HDP)
18,000
Open
High
Low
Vol
Market Cap.178.82
Remain Bid2,700
Remain Ask11,100
52Wk High19,000
52Wk Low12,800
52Wk Avg Vol1,247
Foreign Buy-
Frgn Owned(%)-
Dividend1,600
Dividend Yield0.09
Beta-0.02
EPS434
P/E41.51
F P/E14.90
BVPS13,684
P/B1.32
Date | Close | Change | Volume |
---|---|---|---|
04/19/2024 | 18,000 | 0 (0.00%) | 0 |
04/17/2024 | 18,000 | 700 (+4.05%) | 6,600 |
04/16/2024 | 17,300 | 0 (0.00%) | 0 |
04/15/2024 | 17,300 | 0 (0.00%) | 0 |
04/12/2024 | 17,300 | -1,000 (-5.46%) | 100 |
05/17/2023 | HDP Dividend payment in cash with 16.00% for 2022 (Record date) |
05/17/2023 | HDP Dividend payment in cash with 16.00% for 2022 |
05/26/2022 | HDP Dividend payment in cash with 10.00% for 2021 (Record date) |
05/26/2022 | HDP Dividend payment in cash with 10.00% for 2021 |
06/11/2021 | HDP Dividend payment in cash with 8.00% for 2020 (Record date) |
03/29/2024 | 2024 Annual Shareholders’Meeting Documents |
03/30/2024 | Annual report 2023 |
03/30/2024 | Audited FS 2023 |
01/18/2024 | Corporate Governance Report 2023 |
07/24/2023 | Corporate Governance Report the first 6 month of 2023 |
Name: Ha Tinh Pharmaceutical JSC
Abbreviation:HADIPHAR
Address: No.167 Ha Huy Tap Street, Nam Ha Ward Ha Tinh Ha Tinh
Telephone: (84.239) 385 4398
Fax: (84.239) 385 6821
Email:htp@hadiphar.vn
Website:http://hadiphar.vn
Exchange: UPCoM
Sector: Manufacturing
Industry: Chemical - Pharmaceutical
Listing date: 03/16/2017
Chartered capital: 99,344,180,000
Listed shares: 9,934,418
Shares outstanding: 9,934,418
Status: Operating
Tax code: 3000104879
Establishment license: 1378 QĐ/UB
Issued date: 09/28/1996
Business license: 3000104879
Issued date: 12/29/2004
Main business scope:
- Producing, trading and import-exporting medicine.
- Producing, trading and import-exporting pharmaceutical ingredients and additives, chemicals, cosmetics, nutritional foods.
- Trading and import-exporting medical supply and equipment.
- Consulting, conducting, and installing medical equipment.
- 03 August 1960: Ha Tinh Pharmaceutical State-Owned Company was established;
- 27 October 2004: Ha Tinh Provincial People's Committee issued Decision No.500/QD-UBND on transforming Ha Tinh Pharmaceutical and Medical Equipment Company into Ha Tinh Pharmaceutical and Medical Equipment Joint Stock Company;
- 29 December 2004: Put into operation under the model of a joint-stock company with an initial charter capital of VND5.5 billion;
- 29 January 2008: Charter capital was raised up to VND12.5 billion;
- 26 December 2008: Became a public company;
- 31 December 2009: Renamed as Ha Tinh Pharmaceutical Joint Stock Company with its charter capital up to VND18.75 billion;
- 22 April 2011: Increased charter capital to VND33,316,740,000;
- 27 June 2013: Increased charter capital to VND58,513,100,000;
- Ngày 30/09/2015: SCIC sold all of their 1,395,900 shares in HADIPHAR, which accounts for 23.86% charter capital. 100% was bought by investors at an average winning bid of VND21,200 per share;
- 16 March 2017: Traded on the UPCOM market;
- 12 December 2017: Increased charter capital to VND61,438,100,000;
- 11 May 2018: Increased charter capital to VND67,581,200,000;
- 27 December 2018: Increased charter capital to VND70,931,200,000;
- May 28, 2019: Increased charter capital to VND78.023.250.000;
- January 20, 2020: Increased charter capital to VND81.923.250.000;
- May 05, 2020: Increased charter capital to VND90.114.180.000.
- September 28, 2021: Increased charter capital to VND94.614.180.000;
- 04/25/2024 HDP General Meeting of Shareholders for 2024
- 12/14/2023 HDP Annoucement of the change of listing - 473,000 shares
- 05/17/2023 HDP Dividend payment in cash with 16.00% for 2022 (Record date)
- 05/17/2023 HDP Dividend payment in cash with 16.00% for 2022
- 04/26/2023 HDP General Meeting of Shareholders for 2023
Items | Unit |
---|---|
Price | VND |
Volume | Shares |
Foreigner's, Yield | % |
Mkt Cap | bVND |
Financial indicators | mVND |
EPS, BVPS, Dividend | VND |
P/E, F P/E, P/B | Times |
ROS, ROA, ROE | % |
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.